Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

PHASE3CompletedINTERVENTIONAL
Enrollment

1,572

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

August 31, 2007

Conditions
Infections, Streptococcal
Interventions
BIOLOGICAL

Pneumococcal (vaccine)

Trial Locations (66)

10315

GSK Investigational Site, Berlin

10967

GSK Investigational Site, Berlin

12627

GSK Investigational Site, Berlin

12679

GSK Investigational Site, Berlin

13355

GSK Investigational Site, Berlin

14197

GSK Investigational Site, Berlin

17300

GSK Investigational Site, Blanes (Girona)

28034

GSK Investigational Site, Madrid

28035

GSK Investigational Site, Madrid

28040

GSK Investigational Site, Marid

28047

GSK Investigational Site, Madrid

28935

GSK Investigational Site, Móstoles/Madrid

29011

GSK Investigational Site, Málaga

29700

GSK Investigational Site, Vélez-Málaga / Málaga

32049

GSK Investigational Site, Herford

32457

GSK Investigational Site, Porta Westfalica

32479

GSK Investigational Site, Hille

32584

GSK Investigational Site, Löhne

37269

GSK Investigational Site, Eschwege

38302

GSK Investigational Site, Wolfenbüttel

47010

GSK Investigational Site, Valladolid

48013

GSK Investigational Site, Bilbao

48163

GSK Investigational Site, Münster

54290

GSK Investigational Site, Trier

54294

GSK Investigational Site, Trier

54568

GSK Investigational Site, Gerolstein

55131

GSK Investigational Site, Mainz

55294

GSK Investigational Site, Bodenheim

55543

GSK Investigational Site, Bad Kreuznach

60389

GSK Investigational Site, Frankfurt am Main

65527

GSK Investigational Site, Niedernhausen

67227

GSK Investigational Site, Frankenthal

67547

GSK Investigational Site, Worms

68167

GSK Investigational Site, Mannheim

68309

GSK Investigational Site, Mannheim

70469

GSK Investigational Site, Stuttgart

71720

GSK Investigational Site, Oberstenfeld

74357

GSK Investigational Site, Bönnigheim

74523

GSK Investigational Site, Schwäbisch Hall

75015

GSK Investigational Site, Bretten

76189

GSK Investigational Site, Karlsruhe

77694

GSK Investigational Site, Kehl

77955

GSK Investigational Site, Ettenheim

81675

GSK Investigational Site, Munich

81735

GSK Investigational Site, Munich

82140

GSK Investigational Site, Olching

86720

GSK Investigational Site, Nördlingen

88069

GSK Investigational Site, Tettnang

88348

GSK Investigational Site, Bad Saulgau

93413

GSK Investigational Site, Cham

93426

GSK Investigational Site, Roding

99425

GSK Investigational Site, Weimar

04720

GSK Investigational Site, Döbeln

02692

GSK Investigational Site, Singwitz

07356

GSK Investigational Site, Bad Lobenstein

85-021

GSK Investigational Site, Bydgoszcz

39-200

GSK Investigational Site, Dębica

Unknown

GSK Investigational Site, Krakow

61-709

GSK Investigational Site, Poznan

41-103

GSK Investigational Site, Siemianowice Śląskie

33-100

GSK Investigational Site, Tarnów

43-225

GSK Investigational Site, Wola

09005

GSK Investigational Site, Burgos

08390

GSK Investigational Site, Montgat/Barcelona

08620

GSK Investigational Site, San T Vicenç Del Horts ( Barcelona)

08551

GSK Investigational Site, Tona/Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY